Skip to main content
Erschienen in: Infection 5/2011

01.10.2011 | Clinical and Epidemiological Study

Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC

verfasst von: V. D. Rosenthal, P. Lynch, W. R. Jarvis, I. A. Khader, R. Richtmann, N. B. Jaballah, C. Aygun, W. Villamil-Gómez, L. Dueñas, T. Atencio-Espinoza, J. A. Navoa-Ng, M. Pawar, M. Sobreyra-Oropeza, A. Barkat, N. Mejía, C. Yuet-Meng, A. Apisarnthanarak, INICC members

Erschienen in: Infection | Ausgabe 5/2011

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To evaluate the impact of country socioeconomic status and hospital type on device-associated healthcare-associated infections (DA-HAIs) in neonatal intensive care units (NICUs).

Methods

Data were collected on DA-HAIs from September 2003 to February 2010 on 13,251 patients in 30 NICUs in 15 countries. DA-HAIs were defined using criteria formulated by the Centers for Disease Control and Prevention. Country socioeconomic status was defined using World Bank criteria.

Results

Central-line-associated bloodstream infection (CLA-BSI) rates in NICU patients were significantly lower in private than academic hospitals (10.8 vs. 14.3 CLA-BSI per 1,000 catheter-days; p < 0.03), but not different in public and academic hospitals (14.6 vs. 14.3 CLA-BSI per 1,000 catheter-days; p = 0.86). NICU patient CLA-BSI rates were significantly higher in low-income countries than in lower-middle-income countries or upper-middle-income countries [37.0 vs. 11.9 (p < 0.02) vs. 17.6 (p < 0.05) CLA-BSIs per 1,000 catheter-days, respectively]. Ventilator-associated-pneumonia (VAP) rates in NICU patients were significantly higher in academic hospitals than in private or public hospitals [13.2 vs. 2.4 (p < 0.001) vs. 4.9 (p < 0.001) VAPs per 1,000 ventilator days, respectively]. Lower-middle-income countries had significantly higher VAP rates than low-income countries (11.8 vs. 3.8 per 1,000 ventilator-days; p < 0.001), but VAP rates were not different in low-income countries and upper-middle-income countries (3.8 vs. 6.7 per 1,000 ventilator-days; p = 0.57). When examined by hospital type, overall crude mortality for NICU patients without DA-HAIs was significantly higher in academic and public hospitals than in private hospitals (5.8 vs. 12.5%; p < 0.001). In contrast, NICU patient mortality among those with DA-HAIs was not different regardless of hospital type or country socioeconomic level.

Conclusions

Hospital type and country socioeconomic level influence DA-HAI rates and overall mortality in developing countries.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Zupan J, Aahman E (editors). Perinatal mortality for the year 2000: estimates developed by WHO. Geneva: World Health Organization; 2005. Zupan J, Aahman E (editors). Perinatal mortality for the year 2000: estimates developed by WHO. Geneva: World Health Organization; 2005.
5.
Zurück zum Zitat Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–88.PubMedCrossRef Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA. Hospital-acquired neonatal infections in developing countries. Lancet. 2005;365:1175–88.PubMedCrossRef
6.
Zurück zum Zitat Foege W. Managing newborn health in the global community. Am J Public Health. 2001;91:1563–4.PubMedCrossRef Foege W. Managing newborn health in the global community. Am J Public Health. 2001;91:1563–4.PubMedCrossRef
7.
Zurück zum Zitat World Health Organization (WHO). Proceedings of meeting of development partners: maternal and newborn health with a focus on country implementation. In: Millennium Development Goals. Stockholm: World Health Organization. 2006. Available at: http://www.who.org. Accessed 26 May 2008. World Health Organization (WHO). Proceedings of meeting of development partners: maternal and newborn health with a focus on country implementation. In: Millennium Development Goals. Stockholm: World Health Organization. 2006. Available at: http://​www.​who.​org. Accessed 26 May 2008.
8.
Zurück zum Zitat Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582–91.PubMed Rosenthal VD, Maki DG, Salomao R, Moreno CA, Mehta Y, Higuera F, et al. Device-associated nosocomial infections in 55 intensive care units of 8 developing countries. Ann Intern Med. 2006;145:582–91.PubMed
9.
Zurück zum Zitat Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36:e1–12.PubMedCrossRef Rosenthal VD, Maki DG, Graves N. The International Nosocomial Infection Control Consortium (INICC): goals and objectives, description of surveillance methods, and operational activities. Am J Infect Control. 2008;36:e1–12.PubMedCrossRef
10.
Zurück zum Zitat Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, et al. International Nosocomial Infection Control Consortium report. Data summary for 2002–2007, issued January 2008. Am J Infect Control. 2008;36:627–37.PubMedCrossRef Rosenthal VD, Maki DG, Mehta A, Alvarez-Moreno C, Leblebicioglu H, Higuera F, et al. International Nosocomial Infection Control Consortium report. Data summary for 2002–2007, issued January 2008. Am J Infect Control. 2008;36:627–37.PubMedCrossRef
11.
Zurück zum Zitat Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY et al. International Nosocomial Infection Control Consortium (INICC) report. Data summary for 2003-2008, issued June 2009. Am J Infect Control. 38:95–104 e2. doi:10.1016/j.ajic.2009.12.004. Rosenthal VD, Maki DG, Jamulitrat S, Medeiros EA, Todi SK, Gomez DY et al. International Nosocomial Infection Control Consortium (INICC) report. Data summary for 2003-2008, issued June 2009. Am J Infect Control. 38:95–104 e2. doi:10.​1016/​j.​ajic.​2009.​12.​004.
12.
Zurück zum Zitat Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.PubMedCrossRef Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988;16:128–40.PubMedCrossRef
15.
Zurück zum Zitat Haley RW, Quade D, Freeman HE, Bennett JV. The senic project. Study on the efficacy of nosocomial infection control (SENIC project). Summary of study design. Am J Epidemiol. 1980;111:472–85.PubMed Haley RW, Quade D, Freeman HE, Bennett JV. The senic project. Study on the efficacy of nosocomial infection control (SENIC project). Summary of study design. Am J Epidemiol. 1980;111:472–85.PubMed
16.
Zurück zum Zitat Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National nosocomial infections surveillance system. Am J Med. 1991;91:185S–91S.PubMedCrossRef Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States. National nosocomial infections surveillance system. Am J Med. 1991;91:185S–91S.PubMedCrossRef
17.
Zurück zum Zitat National Nosocomial Infections Surveillance (NNIS) system report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85. National Nosocomial Infections Surveillance (NNIS) system report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32:470–85.
18.
19.
Zurück zum Zitat Madani N, Rosenthal VD, Dendane T, Abidi K, Zeggwagh AA, Abouqal R. Health-care associated infections rates, length of stay, and bacterial resistance in an intensive care unit of morocco: findings of the International Nosocomial Infection Control Consortium (INICC). Int Arch Med. 2009;2:29.PubMedCrossRef Madani N, Rosenthal VD, Dendane T, Abidi K, Zeggwagh AA, Abouqal R. Health-care associated infections rates, length of stay, and bacterial resistance in an intensive care unit of morocco: findings of the International Nosocomial Infection Control Consortium (INICC). Int Arch Med. 2009;2:29.PubMedCrossRef
20.
Zurück zum Zitat Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgultekin A, Yalcin AN, Koksal I, et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;65:251–7.PubMedCrossRef Leblebicioglu H, Rosenthal VD, Arikan OA, Ozgultekin A, Yalcin AN, Koksal I, et al. Device-associated hospital-acquired infection rates in Turkish intensive care units. Findings of the International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;65:251–7.PubMedCrossRef
21.
Zurück zum Zitat Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of The International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;67:168–74.PubMedCrossRef Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, et al. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of The International Nosocomial Infection Control Consortium (INICC). J Hosp Infect. 2007;67:168–74.PubMedCrossRef
22.
Zurück zum Zitat Salomao R, Rosenthal VD, Grinberg G, Nouer S, Blecher S, Buchner-Ferreira S, et al. Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica. 2008;24:195–202.PubMedCrossRef Salomao R, Rosenthal VD, Grinberg G, Nouer S, Blecher S, Buchner-Ferreira S, et al. Device-associated infection rates in intensive care units of Brazilian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica. 2008;24:195–202.PubMedCrossRef
23.
Zurück zum Zitat Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, et al. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica. 2008;24:16–24.PubMedCrossRef Cuellar LE, Fernandez-Maldonado E, Rosenthal VD, Castaneda-Sabogal A, Rosales R, Mayorga-Espichan MJ, et al. Device-associated infection rates and mortality in intensive care units of Peruvian hospitals: findings of the International Nosocomial Infection Control Consortium. Rev Panam Salud Publica. 2008;24:16–24.PubMedCrossRef
24.
Zurück zum Zitat Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol. 2004;25:251–5.PubMedCrossRef Rosenthal VD, Guzman S, Crnich C. Device-associated nosocomial infection rates in intensive care units of Argentina. Infect Control Hosp Epidemiol. 2004;25:251–5.PubMedCrossRef
25.
Zurück zum Zitat Ramirez Barba EJ, Rosenthal VD, Higuera F, Oropeza MS, Hernandez HT, Lopez MS, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control. 2006;34:244–7.PubMedCrossRef Ramirez Barba EJ, Rosenthal VD, Higuera F, Oropeza MS, Hernandez HT, Lopez MS, et al. Device-associated nosocomial infection rates in intensive care units in four Mexican public hospitals. Am J Infect Control. 2006;34:244–7.PubMedCrossRef
26.
Zurück zum Zitat Rosenthal VD. Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2008;36:S171 e7–12. Rosenthal VD. Device-associated nosocomial infections in limited-resources countries: findings of the International Nosocomial Infection Control Consortium (INICC). Am J Infect Control. 2008;36:S171 e7–12.
27.
Zurück zum Zitat Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control. 2003;31:291–5.PubMedCrossRef Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control. 2003;31:291–5.PubMedCrossRef
28.
Zurück zum Zitat Pawar M, Mehta Y, Purohit A, Trehan N, Rosenthal VD. Resistance in gram-negative bacilli in a cardiac intensive care unit in India: risk factors and outcome. Ann Card Anaesth. 2008;11:20–6.PubMedCrossRef Pawar M, Mehta Y, Purohit A, Trehan N, Rosenthal VD. Resistance in gram-negative bacilli in a cardiac intensive care unit in India: risk factors and outcome. Ann Card Anaesth. 2008;11:20–6.PubMedCrossRef
29.
Zurück zum Zitat Lynch P, Rosenthal VD, Borg MA, Eremin SR. Infection control in developing countries. In: Jarvis WR, editor. Bennett and Brachman’s hospital infections. Philadelphia: Lipppincott Williams & Wilkins; 2007. p. 255. Lynch P, Rosenthal VD, Borg MA, Eremin SR. Infection control in developing countries. In: Jarvis WR, editor. Bennett and Brachman’s hospital infections. Philadelphia: Lipppincott Williams & Wilkins; 2007. p. 255.
30.
Zurück zum Zitat Rosenthal VD. Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis. 2009;49:1899–907.PubMedCrossRef Rosenthal VD. Central line-associated bloodstream infections in limited-resource countries: a review of the literature. Clin Infect Dis. 2009;49:1899–907.PubMedCrossRef
31.
Zurück zum Zitat Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006;27:349–56.PubMedCrossRef Moreno CA, Rosenthal VD, Olarte N, Gomez WV, Sussmann O, Agudelo JG, et al. Device-associated infection rate and mortality in intensive care units of 9 Colombian hospitals: findings of the International Nosocomial Infection Control Consortium. Infect Control Hosp Epidemiol. 2006;27:349–56.PubMedCrossRef
32.
Zurück zum Zitat Rezende EM, Couto BR, Starling CE, Modena CM. Prevalence of nosocomial infections in general hospitals in Belo Horizonte. Infect Control Hosp Epidemiol. 1998;19:872–6.PubMedCrossRef Rezende EM, Couto BR, Starling CE, Modena CM. Prevalence of nosocomial infections in general hospitals in Belo Horizonte. Infect Control Hosp Epidemiol. 1998;19:872–6.PubMedCrossRef
33.
Zurück zum Zitat Pessoa-Silva CL, Richtmann R, Calil R, Santos RM, Costa ML, Frota AC, et al. Healthcare-associated infections among neonates in Brazil. Infect Control Hosp Epidemiol. 2004;25:772–7. doi:10.1086/502475.PubMedCrossRef Pessoa-Silva CL, Richtmann R, Calil R, Santos RM, Costa ML, Frota AC, et al. Healthcare-associated infections among neonates in Brazil. Infect Control Hosp Epidemiol. 2004;25:772–7. doi:10.​1086/​502475.PubMedCrossRef
34.
Zurück zum Zitat Chandra PN, Milind K. Lapses in measures recommended for preventing hospital-acquired infection. J Hosp Infect. 2001;47:218–22.PubMedCrossRef Chandra PN, Milind K. Lapses in measures recommended for preventing hospital-acquired infection. J Hosp Infect. 2001;47:218–22.PubMedCrossRef
35.
Zurück zum Zitat Hugonnet S, Harbarth S, Sax H, Duncan RA, Pittet D. Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis. 2004;17:329–33.PubMedCrossRef Hugonnet S, Harbarth S, Sax H, Duncan RA, Pittet D. Nursing resources: a major determinant of nosocomial infection? Curr Opin Infect Dis. 2004;17:329–33.PubMedCrossRef
36.
Zurück zum Zitat Rosenthal VD, Guzman S, Crnich C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control. 2006;34:58–63.PubMedCrossRef Rosenthal VD, Guzman S, Crnich C. Impact of an infection control program on rates of ventilator-associated pneumonia in intensive care units in 2 Argentinean hospitals. Am J Infect Control. 2006;34:58–63.PubMedCrossRef
37.
Zurück zum Zitat Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med. 2005;33:2022–7.PubMedCrossRef Higuera F, Rosenthal VD, Duarte P, Ruiz J, Franco G, Safdar N. The effect of process control on the incidence of central venous catheter-associated bloodstream infections and mortality in intensive care units in Mexico. Crit Care Med. 2005;33:2022–7.PubMedCrossRef
38.
Zurück zum Zitat Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control. 2005;33:392–7.PubMedCrossRef Rosenthal VD, Guzman S, Safdar N. Reduction in nosocomial infection with improved hand hygiene in intensive care units of a tertiary care hospital in Argentina. Am J Infect Control. 2005;33:392–7.PubMedCrossRef
39.
Zurück zum Zitat Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25:47–50.PubMedCrossRef Rosenthal VD, Guzman S, Safdar N. Effect of education and performance feedback on rates of catheter-associated urinary tract infection in intensive care units in Argentina. Infect Control Hosp Epidemiol. 2004;25:47–50.PubMedCrossRef
40.
Zurück zum Zitat Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control. 2003;31:405–9.PubMedCrossRef Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control. 2003;31:405–9.PubMedCrossRef
Metadaten
Titel
Socioeconomic impact on device-associated infections in limited-resource neonatal intensive care units: findings of the INICC
verfasst von
V. D. Rosenthal
P. Lynch
W. R. Jarvis
I. A. Khader
R. Richtmann
N. B. Jaballah
C. Aygun
W. Villamil-Gómez
L. Dueñas
T. Atencio-Espinoza
J. A. Navoa-Ng
M. Pawar
M. Sobreyra-Oropeza
A. Barkat
N. Mejía
C. Yuet-Meng
A. Apisarnthanarak
INICC members
Publikationsdatum
01.10.2011
Verlag
Springer-Verlag
Erschienen in
Infection / Ausgabe 5/2011
Print ISSN: 0300-8126
Elektronische ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-011-0136-2

Weitere Artikel der Ausgabe 5/2011

Infection 5/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.